Cited by 19Cellular transport and secretionHER2/EGFR in Cancer ResearchAutophagy in Disease and Therapy

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index; none of the 35 sources its claims cite is checked for support yet.

Clathrin adapters AP-1 and GGA2 support expression of epidermal growth factor receptor for cell growth

Open access

Abstract

The role of Golgi/endosome-localized clathrin adapters in the maintenance of steady-state cell surface epidermal growth factor receptor (EGFR) is not well known. Here, we show that EGFR associates preferentially with both AP-1 and GGA2 in vitro. AP-1 depletion caused a reduction in the EGFR protein by promoting its lysosomal degradation. Triple immunofluorescence microscopy and proximity ligation assays demonstrated that the interaction of EGFR with AP-1 or GGA2 occurred more frequently in Rab11-positive recycling endosomes than in Rab5-positive early endosomes. Biochemical recycling assay revealed that the depletion of AP-1 or GGA2 significantly suppressed EGFR recycling to the plasma membrane regardless of the EGF stimulation. Depletion of AP-1 or GGA2 also reduced cell contents of other tyrosine kinases, MET and ErbB4, and therefore, suppressed the growth of H1975 cancer cells in culture and xenograft model. Moreover, AP-1 was expressed in endosomes at higher levels in some cancer tissues. Collectively, these results suggest that AP-1 and GGA2 function in recycling endosomes to retrieve endocytosed EGFR, thereby sustaining its cell surface expression and, consequently, cancer cell growth.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

AP-1 and GGA2 interact with EGFR preferentially in Rab11-positive recycling endosomes and support EGFR recycling to the plasma membrane, thereby maintaining cell surface EGFR and cell growth. Depletion of AP-1 or GGA2 reduces EGFR and other RTKs, suppresses cancer cell growth in culture and xenografts, and AP-1 distribution is altered in some human cancers.

Key findings

  • AP-1 depletion reduced EGFR protein by accelerating its lysosomal degradation; pulse-chase showed significantly increased EGFR turnover (P < 0.01–0.05), while EGFR mRNA and newly translated protein were unchanged.
  • AP-1 and GGA2 interacted with EGFR preferentially in Rab11-positive recycling endosomes: about 49–52% of AP-1/GGA2–EGFR PLA signal overlapped with Rab11-positive structures versus 13–15% with Rab5-positive ones.
  • Depletion of AP-1 or GGA2 significantly reduced cell surface EGFR (P < 0.001) and EGFR recycling to the plasma membrane (P < 0.05 or 0.01) regardless of EGF stimulation; MET and ErbB4 were also decreased.
  • AP-1 depletion suppressed growth of ARPE-19 and H1975 cells in culture (P < 0.05–0.001) and H1975 xenograft tumor growth (P < 0.001); AP-1-positive granular structures were more evident in tumor versus non-tumor regions in 68–84% of cancer tissues, with significantly higher mean intensity in NSCLC but not HCC or CRC.

Methods

  • Immunoprecipitation coupled with mass spectrometry and western blotting in ARPE-19 and H1975 cells identified EGFR-associated clathrin adapters; siRNA/shRNA knockdown of AP-1 subunits or GGA2 was used for functional assays.
  • EGFR trafficking was analyzed by pulse-chase with [35S]-methionine/cysteine, surface biotinylation, internalization/recycling assays, immunofluorescence microscopy, and proximity ligation assays.
  • Cell growth was measured in culture and in H1975 xenografts; human tissue arrays of HCC, NSCLC, and CRC were immunostained, with statistical comparisons by Student’s t-test or Mann–Whitney U-test.

Limitations

  • The paper states that whether AP-1/GGA2 interact with liganded and/or non-liganded EGFR remains a future issue, and that predicted growth effects in cancer tissues may not be mediated solely by EGFR upregulation.
  • The paper also states that clathrin adapter-associated molecules such as Arf1 and accessory proteins need to be investigated using human samples.
  • Evident from the text: mechanistic conclusions rely mainly on ARPE-19 and H1975 cell lines plus an H1975 xenograft, and human tissue analysis is limited to expression/distribution in arrays without direct functional perturbation; AP-1 mean intensity was not significantly higher in HCC or CRC.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41389-021-00367-2

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 35 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    Depletion of AP-1 or GGA2 increases CIMPR in both total and cell surface fractions.

    “One of well-known cargoes of AP-1/GGA2, cation independent (CI) MPR was rather increased by the depletion of AP-1/GGA2 in both total and cell surface fraction, which is consistent with previous data [25–27].”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites [25] Ghosh P, Griffith J, Geuze HJ, Kornfeld S. Mammalian GGAs act together to sort mannose 6-phosphate receptors. J Cell Biol. 2003;163:755–66. source
    • cites [26] Meyer C, Eskelinen EL, Guruprasad MR, von Figura K, Schu P. Mu 1A deficiency induces a profound increase in MPR300/IGF-II receptor internalization rate. J Cell Sci. 2001;114:4469–76. source
    • cites [27] Navarro Negredo P, Edgar JR, Wrobel AG, Zaccai NR, Antrobus R, Owen DJ, et al. Contribution of the clathrin adaptor AP-1 subunit micro1 to acidic cluster protein sorting. J Cell Biol. 2017;216:2927–43. source
  • Findingown data

    Depletion of AP-1 or GGA2 significantly suppresses EGFR recycling to the plasma membrane regardless of EGF stimulation.

    “Biochemical recycling assay revealed that the depletion of AP-1 or GGA2 significantly suppressed EGFR recycling to the plasma membrane regardless of the EGF stimulation.”
    • Also stated in: § AP-1 and GGA2 support recycling of EGFR back to the PM · hedged
      “These results together with the PLA data under EGF stimulation as described above (Supplementary Fig. S4C) suggest that AP-1 and GGA2 support the recycling of EGFR regardless of the EGF stimulation.”
    Quote in the paperSubstantial claim
  • Findingown data

    EGFR associates preferentially with both AP-1 and GGA2 in vitro.

    “Here, we show that EGFR associates preferentially with both AP-1 and GGA2 in vitro.”
    • Also stated in: § AP-1-depletion causes a reduction of EGFR protein · boosted
      “These assays revealed a strong EGFR interaction with AP-1 and GGA2 and a weak interaction with AP-4 and AP-5, and little interaction with AP-3, GGA1, or GGA3 in both cell-types (Fig. 1B).”
    Quote in the paperSubstantial claim
  • Findingown data

    The interaction of EGFR with AP-1 or GGA2 occurs more frequently in Rab11-positive recycling endosomes than in Rab5-positive early endosomes.

    “Triple immunofluorescence microscopy and proximity ligation assays demonstrated that the interaction of EGFR with AP-1 or GGA2 occurred more frequently in Rab11-positive recycling endosomes than in Rab5-positive early endosomes.”
    • Also stated in: § AP-1 and GGA2 interact with EGFR at the recycling endosomes · hedged
      “Quantification revealed that about 49–52% of the signal for AP-1/GGA2–EGFR interaction overlapped with Rab11-positive structures, while it was 13–15% with Rab5-positive ones (Fig. 4D), indicating that the interactions between AP-1/GGA2 and EGFR occur preferentially in the recycling endosomes.”
    Quote in the paperSubstantial claim
  • Findingown data

    Depletion of AP-1 or GGA2 reduces MET in H1975 cells.

    “In H1975 cells that have minimal expression of Erb-B4 (Supplementary Fig. S6B), MET were significantly decreased by AP-1/GGA2 depletion (P < 0.01 or 0.001; Fig. 7B and Supplementary Fig. S6A).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim. 18
  • It may state two separate claims as one. 11
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Findingnone given

    AP-1 is expressed in endosomes at higher levels in some cancer tissues.

    “Moreover, AP-1 was expressed in endosomes at higher levels in some cancer tissues.”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Findingown data

    Mean AP-1 signal intensity was significantly higher in tumor than in non-tumor cells in NSCLC, but not in HCC or CRC.

    “When the mean signal intensity was quantified, it was significantly higher in tumor than in non-tumor cells in NSCLC, but not in HCC or CRC (Fig. 8D)”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Findingown data

    Knockdown of AP-1 or GGA2 increases lysosomal degradation of EGFR and decreases its recycling to the plasma membrane.

    “Given that the lysosomal degradation of EGFR is increased and its recycling to the PM is decreased by the knockdown of AP-1 (present study) and GGA2 (present study and [15])”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [15] Uemura T, Kametaka S, Waguri S. GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth. Sci Rep. 2018;8:1368. source
  • It may state two separate claims as one.

    Findingown data

    AP-1 punctate signals overlapped well with EEA1-positive endosomes, but not at all or only partially with the TGN marker TGN46 in HCC, NSCLC, and CRC.

    “double immunofluorescence microscopy demonstrated that punctate signals for AP-1 overlapped well with EEA1-positive endosomes, but not at all or only partially with the TGN marker TGN46 in HCC, NSCLC, and CRC (Fig. 8E and Supplementary Fig. S7E).”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Premisecitation

    Cell surface EGFR is constitutively internalized and recycled back to the plasma membrane without ligand stimulation, and this balance is precisely regulated for maintenance of the cell surface-dominant localization of the receptor.

    “Cell surface EGFR is also constitutively internalized and recycled back to the PM without ligand stimulation; this balance must be precisely regulated for the maintenance of the cell surface-dominant localization of the receptor [3, 4].”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [3] Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res. 2008;314:3093–106. source
    • cites [4] Tomas A, Futter CE, Eden ER. EGF receptor trafficking: consequences for signaling and cancer. Trends Cell Biol. 2014;24:26–34. source
  • Probably not a substantial claim.

    Premisecitation

    Ligand-stimulated EGFR is recycled back to the plasma membrane through Rab11-positive endosomes.

    “Since AP-1 has been shown to localize to Rab11-positive recycling endosomes [28], and ligand-stimulated EGFR is recycled back to the PM through Rab11-positive endosomes [29, 30], we examined if three molecules, EGFR, AP-1, and Rab11, could show colocalization in the cytoplasm.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [29] Tong J, Sydorskyy Y, St-Germain JR, Taylor P, Tsao MS, Moran MF. Odin (ANKS1A) modulates EGF receptor recycling and stability. PLoS ONE. 2013;8:e64817. source
    • cites [30] Chi S, Cao H, Wang Y, McNiven MA. Recycling of the epidermal growth factor receptor is mediated by a novel form of the clathrin adaptor protein Eps15. J Biol Chem. 2011;286:35196–208. source
  • Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.

    Premisecitation

    EGFR plays key roles in normal cellular functions and in the development of several types of cancer.

    “The EGFR plays key roles not only in normal cellular functions but also in the development of several types of cancer cells [1, 2], and therefore, it is the therapeutic targets of several anti-cancer drugs.”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [1] Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141:1117–34. source
    • cites [2] Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2:127–37. source
  • Probably not a substantial claim.

    Premisecitation

    AP-1 localizes to Rab11-positive recycling endosomes.

    “Since AP-1 has been shown to localize to Rab11-positive recycling endosomes [28], and ligand-stimulated EGFR is recycled back to the PM through Rab11-positive endosomes [29, 30], we examined if three molecules, EGFR, AP-1, and Rab11, could show colocalization in the cytoplasm.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [28] Matsudaira T, Niki T, Taguchi T, Arai H. Transport of the cholera toxin B-subunit from recycling endosomes to the Golgi requires clathrin and AP-1. J Cell Sci. 2015;128:3131–42. source
  • Probably not a substantial claim.

    Premisecitation

    GGA2 maintains the cell surface expression of EGFR necessary for robust cell growth.

    “GGA2 reportedly maintains the cell surface expression of EGFR necessary for robust cell growth [15]”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [15] Uemura T, Kametaka S, Waguri S. GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth. Sci Rep. 2018;8:1368. source
  • It may state two separate claims as one.

    Interpretationown data

    AP-1 and GGA2 function in recycling endosomes to retrieve endocytosed EGFR, thereby sustaining its cell surface expression and consequently cancer cell growth.

    “Collectively, these results suggest that AP-1 and GGA2 function in recycling endosomes to retrieve endocytosed EGFR, thereby sustaining its cell surface expression and, consequently, cancer cell growth.”
    • Also stated in: § Introduction · plain
      “Here, we present evidence that AP-1 together with GGA2 controls EGFR recycling from endosomes, maintaining its cell surface expression and cell growth.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Interpretationreasoning

    Predicted growth effects in cancer tissues may not be mediated solely by the upregulation of EGFR.

    “However, predicted growth effects in cancer tissues may not be mediated solely by the upregulation of EGFR.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim.

    Study design and conductown data

    Depletion of γ1-adaptin and EGFR was confirmed by western blotting.

    “Depletion of γ1-adaptin and EGFR was confirmed by western blotting using the indicated antibodies (Ab).”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Interpretationreasoning

    Potential AP-1/GGA2 targeting as an anti-cancer strategy is not dependent on activation mutations but on the intracellular recycling of EGFR.

    “Nevertheless, it should be emphasized that potential AP-1/GGA2 targeting as an anti-cancer strategy is not dependent on activation mutations but on the intracellular recycling of EGFR, and that AP-1/GGA2 targeting could arrest multiple cancer-related signaling pathways that originate from different RTKs.”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Interpretationown data

    GGA3 mainly functions in ligand-stimulated endocytosis and/or ubiquitin-dependent degradation of EGFR.

    “Probably, GGA3 mainly functions in ligand-stimulated endocytosis and/or ubiquitin-dependent degradation of EGFR, since it hardly associated with EGFR at steady-state in this study (Fig. 1A).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Premisecitation

    μ1A-adaptin (AP1M1) has cell growth-promoting functions in hepatitis B virus-transfected HepG2 cells.

    “and of μ1A-adaptin (AP1M1) in hepatitis B virus-transfected HepG2 cells [39].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [39] Kou Y, Yan X, Liu Q, Wei X, Zhang B, Li X, et al. HBV upregulates AP-1 complex subunit mu-1 expression via the JNK pathway to promote proliferation of liver cancer cells. Oncol Lett. 2019;18:456–64. source
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Premisecitation

    GGA2 gene is a cooperative driver of EGFR-mediated lung adenocarcinoma.

    “GGA2 gene has been identified as a cooperative driver of EGFR-mediated lung adenocarcinoma [16]”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [16] O’Farrell H, Harbourne B, Kurlawala Z, Inoue Y, Nagelberg AL, Martinez VD, et al. Integrative genomic analyses identifies GGA2 as a cooperative driver of EGFR-mediated lung tumorigenesis. J Thorac Oncol. 2019;14:656–71. source
  • Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.

    Premisecitation

    AP-1 localizes to Rab11-positive recycling endosomes, promoting retrograde transport of cholera toxin B-subunit from endosomes to the Golgi complex.

    “AP-1 has been shown to localize to Rab11-positive recycling endosomes, thereby promoting retrograde transport of the cholera toxin B-subunit from endosomes to the Golgi complex [28].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [28] Matsudaira T, Niki T, Taguchi T, Arai H. Transport of the cholera toxin B-subunit from recycling endosomes to the Golgi requires clathrin and AP-1. J Cell Sci. 2015;128:3131–42. source
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Premisecitation

    μ1A-adaptin has been identified as a possible predictive marker of metastasis to the central nervous system in triple-negative breast cancer.

    “Moreover, μ1A-adaptin has been recently identified by proteomics analysis as a possible predictive marker of metastasis to the central nervous system in triple-negative breast cancer [40].”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [40] Rojas LK, Trilla-Fuertes L, Gamez-Pozo A, Chiva C, Sepulveda J, Manso L, et al. Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer. Ecancermedicalscience. 2019;13:891. source
  • Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.

    Premisecitation

    Ligand-stimulated EGFR is recycled back to the plasma membrane through Rab11-positive endosomes, promoted by the short form of EPS15 and Odin.

    “Previous studies have demonstrated that ligand-stimulated EGFR is recycled back to the PM through Rab11-positive endosomes, which is promoted by the short form of EPS15 [30] and a tyrosine-phosphorylated component, Odin [29, 30].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [30] Chi S, Cao H, Wang Y, McNiven MA. Recycling of the epidermal growth factor receptor is mediated by a novel form of the clathrin adaptor protein Eps15. J Biol Chem. 2011;286:35196–208. source
    • cites [29] Tong J, Sydorskyy Y, St-Germain JR, Taylor P, Tsao MS, Moran MF. Odin (ANKS1A) modulates EGF receptor recycling and stability. PLoS ONE. 2013;8:e64817. source
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Premisecitation

    AP-1 has cell growth-promoting functions in Arabidopsis.

    “Previous studies have reported cell growth-promoting functions of AP-1 in Arabidopsis [38]”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [38] Park M, Song K, Reichardt I, Kim H, Mayer U, Stierhof YD, et al. Arabidopsis mu-adaptin subunit AP1M of adaptor protein complex 1 mediates late secretory and vacuolar traffic and is required for growth. Proc Natl Acad Sci USA. 2013;110:10318–23. source
  • Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.

    Study design and conductreasoning

    Studies on human samples were approved by the Institutional Review Board in Fukushima Medical University (approval number 2943), and informed consent was properly obtained.

    “Studies on human samples were approved by the Institutional Review Board in Fukushima Medical University (approval number: 2943). For each human sample, informed consent was properly obtained as stated by the supplying companies (http://www.outdobiotech.com/strictsops.html).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Premisecitation

    GGA3 promotes lysosomal degradation of EGFR after EGF stimulation.

    “It should be noted that GGA3 has been previously shown to promote the lysosomal degradation of EGFR [12] after stimulation of EGF.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [12] Puertollano R, Bonifacino JS. Interactions of GGA3 with the ubiquitin sorting machinery. Nat Cell Biol. 2004;6:244–51. source
  • Probably not a substantial claim.

    Study design and conductnone given

    The EGFR internalization and recycling assay was confirmed to be within a range where band intensity is linearly proportional to protein concentration.

    “This experimental assay was confirmed to be carried out within a range, where the band intensity is linearly proportional to the protein concentration.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Premisecitation

    MET is overexpressed in HCC.

    “since MET is known to be overexpressed in this type of tumor [42]”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [42] Giordano S, Columbano A. Met as a therapeutic target in HCC: facts and hopes. J Hepatol. 2014;60:442–52. source
  • Probably not a substantial claim.

    Premisecitation

    AP-1 μ1-adaptin can recognize the tyrosine-based motif Y974RAL and YXXΦ-independent interfaces in the cytoplasmic domains of EGFR.

    “It has been reported that the μ1-adaptin subunit of AP-1 can recognize the tyrosine-based motif, Y974RAL, and YXXΦ-independent interfaces in the cytoplasmic domains of EGFR [34, 35]”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites [34] Huang F, Nesterov A, Carter RE, Sorkin A. Trafficking of yellow-fluorescent-protein-tagged mu1 subunit of clathrin adaptor AP-1 complex in living cells. Traffic. 2001;2:345–57. source
    • cites [35] Sorkina T, Bild A, Tebar F, Sorkin A. Clathrin, adaptors and eps15 in endosomes containing activated epidermal growth factor receptors. J Cell Sci. 1999;112:317–27. source
25 of 25
  • The paper relies on this without support.

    The molecular mechanisms of steady-state recycling of EGFR are poorly understood.

    “However, the molecular mechanisms of this steady-state recycling of EGFR are poorly understood.”
  • The paper relies on this without support.

    No study has explored the function of APs in the context of EGFR stability.

    “However, to our knowledge, no study has explored the function of APs in the context of EGFR stability.”
  • The paper relies on this without support.

    Activated EGFRs are internalized and transported into endosomes, where they are ubiquitinated by CBL and translocated into internal vesicles by ESCRT complexes, and finally transported into lysosomes for degradation.

    “The fate of EGFR after ligand-binding has been intensively studied; activated EGFRs are internalized and transported into endosomes, where the receptors are ubiquitinated by CBL and translocated into internal vesicles by the action of ESCRT complexes, and finally transported into lysosomes for degradation.”
  • The paper relies on this without support.

    H1975 cell growth depends on EGFR.

    “since the growth of NSCLC-derived H1975 cells used in this study is known to depend on the EGFR”
  • The paper relies on this without support.

    The AP-1 complex can function when it is recruited onto membrane compartments.

    “the AP-1 complex can function when it is recruited onto the membrane compartments”
5 of 5

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Uemura, T., Suzuki, T., Dohmae, N., & Waguri, S.
Affiliations
  • Fukushima Medical University (JP)
  • RIKEN Center for Sustainable Resource Science (JP)
Corresponding author
Waguri, Satoshi
Venue
Oncogenesis
Published
2021-11-19
Volume
10
Issue
11
Pages
80-80
ISSN
2157-9024 (ISSN-L)
OpenAlex
W3211778058
Cited by
19
References
45
Citations by year
2026: 6 · 2025: 2 · 2024: 4 · 2023: 5 · 2022: 2
FWCI
0.62
Type
journal article
Language
en
Open access
Locations
  • Oncogenesis (publishedVersion, cc-by)
  • SSRN Electronic Journal (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
MEXT | Japan Society for the Promotion of Science (24659088, 15H04670, 26830080)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords
epidermal growth factor receptor, AP-1, GGA2, recycling endosomes, early endosomes, receptor recycling, lysosomal degradation, MET, ErbB4, tyrosine kinase, cancer cell growth

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review